Other causes and condition that may well have to be ruled out by a component diagnostician in the workup for apparent or believed memory loss as well  may be anemia .  The patient may well wonder why after all this time , that they are being checked for anemia in their blood , and low hemoglobin iron blood levels , when they have not been checked for this condition in many many years – indeed eons – and in addition are well past childbearing age.

Severe anemia can well cause a type or types of memory loss and conditions of memory losses.  In addition many types of conditions from severe hemorrhoids to a poor diet can cause anemia.

Other medical conditions as well as scenarios , tests and procedures  that have to be looked into ,  followed up, checked and verified as well as  ruled out in the process of memory tests , at memory clinics and the like in the workup to the diagnosis of memory loss and in this case to determine , ascertain or rule out Alzheimer’s Disease include:

- thyroid disorders and conditions

-  liver and kidney

- heart , cardiac and circulatory disorders

- homocysteine and c-reactive proteins

- EKG workup

- Cardioid check and ultrasound tests

Dimebon Alzheimer?s Disease

http://www.dimebonalzheimers.com


Add URL to Health and Medicine Directory



Add URL to Health and Medicine Directory


Aricept was approved by the FDA for treating severe Alzheimer’s patients making it one of the few drugs indicated for all three stages of Alzheimer’s disease

Three preliminary studies have indicated and reported that patients who take Aricept have slightly less Alzheimer’s related loss in brain volume and volumes than those not being prescribed and taking the medication

A major three year study by the National Institutes of Health found that Aricept helped delay dementia for about eighteen months in patients with MCI.? At thirty six months, only a small subset of participants maintained these benefits. those with APOE4 gene , which increases a person’s risks of developing Alzheimer’s.

Aricept is one of the few CHeI studied exclusively in elderly African Americans with Alzheimer’s who had a similar response to others.? But because ethnic groups metabolize some drugs differently scientists view drugs in diverse ethnic groups more favorably.? At present most of the FDA approved meditations have been studied in Asians as well as Latin American ethnic groups.

Dimebon Alzheimer?s Disease

http://www.dimebonalzheimers.com